NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 238 filers reported holding NEOGENOMICS INC in Q1 2019. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $38,000 | -98.0% | 1,390 | -97.9% | 0.00% | -96.6% |
| Q4 2019 | $1,908,000 | +23.2% | 65,232 | -19.5% | 0.03% | +16.0% |
| Q3 2019 | $1,549,000 | -5.1% | 81,034 | +8.9% | 0.02% | -7.4% |
| Q2 2019 | $1,633,000 | +291.6% | 74,426 | +264.6% | 0.03% | +237.5% |
| Q1 2019 | $417,000 | – | 20,411 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,785,605 | $86,138,000 | 34.19% |
| PERKINS CAPITAL MANAGEMENT INC | 157,750 | $7,610,000 | 4.71% |
| Blue Water Life Science Advisors, LP | 222,222 | $10,719,000 | 3.49% |
| First Light Asset Management, LLC | 1,055,960 | $50,940,000 | 3.36% |
| Ranger Investment Management | 810,956 | $39,121,000 | 2.09% |
| Bullseye Asset Management LLC | 108,054 | $5,212,000 | 1.81% |
| Lombard Odier Asset Management (Switzerland) SA | 584,281 | $28,186,000 | 1.75% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 998,858 | $48,185,000 | 1.67% |
| EMERALD ADVISERS, LLC | 904,298 | $43,623,000 | 1.58% |
| Soleus Capital Management, L.P. | 190,556 | $9,192,000 | 1.43% |